Clorox reported $6.76B of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $6.76B (to Q3 2026). Net income: $601M, trailing twelve months to Q4 2026. Free cash flow: $380M, trailing twelve months to Q3 2026. EPS: $6.16, trailing twelve months to Q3 2026.

CLXClorox

Consumer Defensive

$83.80-30% 1Y

$83.80

$80.4152 weeks$125.58

CLX as reported

Clorox reported $6.76B of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed.

$6.76B

Revenue, trailing twelve months · to Q3 2026 · every figure below is as filed, with no scoring applied

Net income: $601M
Net income · −26% year on year · trailing twelve months to Q4 2026
Free cash flow: $380M
Free cash flow · trailing twelve months to Q3 2026
EPS: $6.16
EPS · trailing twelve months to Q3 2026

Details›

Every series Ryufin has for CLX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$6.76B	n/a	Q3 2026
Net income	$601M	−26%	Q4 2026
EPS	$6.16	n/a	Q3 2026
Gross margin	44%	n/a	Q3 2026
Net margin	11%	n/a	Q3 2026
ROE	−1269%	n/a	Q3 2026
ROA	14%	n/a	Q3 2026
Free cash flow	$380M	n/a	Q3 2026
P/E	17.3	n/a	Q3 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.